Immune disorders
Pro Research Analysisby 
Searched over 200M research papers for "immune disorders"
Immune Disorders: Insights from Recent Research
Primary Immune Regulatory Disorders (PIRD) and Autoimmune Lymphoproliferative Syndrome (ALPS)
Primary immune regulatory disorders (PIRD) are characterized by autoimmunity, autoinflammation, and dysregulation of lymphocyte homeostasis. Autoimmune lymphoproliferative syndrome (ALPS) is a notable PIRD caused by defects in the Fas-FasL pathway, leading to chronic lymphoproliferation, autoimmunity, and an increased risk of lymphoma . ALPS-like disorders, which mimic ALPS but involve different genetic defects, have been identified in over 600 patients with 24 distinct genetic mutations. These include defects in genes such as NRAS, KRAS, and CTLA4, among others . Common clinical manifestations include recurrent infections, skin lesions, enteropathy, and malignancy .
Trained Immunity in Autoimmune and Inflammatory Disorders
Autoimmune and autoinflammatory disorders are marked by a dysregulated immune response towards self-antigens. Monocytes and macrophages (Mo/Ma) play a significant role in these diseases due to their functional and phenotypic plasticity . Trained immunity, a phenomenon where innate immune cells exhibit an enhanced response upon re-exposure to pathogens, can influence the development of autoimmune and autoinflammatory conditions. This is mediated by epigenetic and metabolic changes in Mo/Ma, which can either exacerbate or ameliorate these disorders .
Hematologic Complications in Primary Immune Deficiencies
Primary immune deficiencies (PIDs) are associated with a high incidence of hematologic complications, including immune thrombocytopenic purpura (ITP) and autoimmune hemolytic anemia (AHA) . These complications are particularly common in antibody defects such as common variable immunodeficiency (CVID) and selective immunoglobulin A deficiency. Treatment options for these hematologic issues include corticosteroids, intravenous immunoglobulin (IVIG), and splenectomy .
Diagnostic Challenges in Inborn Errors of Immunity (IEI)
Inborn errors of immunity (IEI), previously known as primary immunodeficiency disorders (PIDs), are genetic disorders that increase susceptibility to infections and immune dysregulation . Diagnosing IEI can be challenging due to the diverse clinical manifestations, which include autoimmune, autoinflammatory, and lymphoproliferative conditions. Modern diagnostic approaches are essential for early and accurate identification of these disorders to improve patient outcomes .
Common Variable Immune Deficiency (CVID) and Associated Complications
Common variable immunodeficiency (CVID) is a primary immune deficiency characterized by defects in antibody production, leading to recurrent infections and various non-infectious complications such as autoimmune disorders, granulomatous interstitial lung disease (GLILD), and malignancies . Management primarily involves immunoglobulin replacement therapy, but immune suppression may be necessary for treating complications, which can increase the risk of infections .
Systems-Based Classification of Autoinflammatory Diseases
Autoinflammatory diseases, initially described as monogenic disorders with periodic fever syndromes, now encompass a broader range of conditions with autoimmune and immunodeficiency components . A systems-based classification approach, which considers various molecular mechanisms and pathways, is proposed to improve the understanding and treatment of these complex disorders. This approach highlights the overlap between autoinflammation, autoimmunity, and immunodeficiency .
Lymphoid Neoplasias in Primary Immunodeficiencies
Patients with primary immunodeficiencies (PIDs) have a higher risk of developing lymphoid neoplasias, particularly B cell lymphomas . This increased susceptibility is often linked to defects in immune regulation and viral infections such as EBV. Understanding the genetic and immunological factors contributing to this risk is crucial for developing targeted therapies .
Conclusion
Recent research highlights the complexity and diversity of immune disorders, emphasizing the need for precise diagnostic and therapeutic strategies. From primary immune regulatory disorders and trained immunity to the hematologic complications of primary immune deficiencies, understanding the underlying mechanisms is key to improving patient outcomes. Advances in systems-based classification and targeted treatments hold promise for better management of these challenging conditions.
Sources and full results
Most relevant research papers on this topic